3Ringel-lmlka T, Palsson OS, Maier D, et al. Probiofic bacteria Lacto- bacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 ver- sus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study [J]. J Clin Gastroenterol, 2011, 45(6): 518-525.
4Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. The fecal mi- crobiota of in'liable bowel syndrome patients differs simificantly from that of healthy subjects [Y]. Gastroenterology, 2007, 133: 24-33.
5Caballero-Franco C, Keller K, Dc Simone C, et al. The VSL#3 pro- biotic formula induces mucin gene expression and secretion in co- lonic epithelial ceils [J. Am J Physiol Gasa'ointest Liver Physiol, 2007, 292(I): G315-G322.
6Rousscaux C, Thuru X, Gelot A, ct al. Lactobacillus acidophilus modulates ivtcstinal pain and induces opioid and cannabinoid recep- tors [J]. Nat Med, 2007, 13(I): 35-37.
7Hovcyda N, Heneghan C, Mahtani K_R, ct al. A systematic review and meta-analysis: probiotics in the a'eaUnent of irritable bowel syn- drome [.11. BMC Gasaz)cnterol, 2009, 9: 15.
8Brenner DM, Moeller M J, Chcy WD, ct al. The utility of probiotics in the trcabncnt of irretabc bowel syndromc:a systematic review [Y]. Am J Gastroenterlol, 2009, 104(4): I033-I049.
10Oerlemans S, van Cranenburgh O, Herremans PJ, et al. Intervening on cognitions nd behavior in irritable bowel syndrome:A feasibility trial using PDAs [J]. J Psychosom Res, 2011, 70(3): 267-277.
